486 related articles for article (PubMed ID: 33089648)
61. [Guidance on the special care of liver or kidney transplant recipients diagnosed with COVID-19].
Remport Á; Gerlei Z; Cseprekál O; Wagner L; Földes K; Marton A; Patonai A; Török S; Haboub-Sandil A; Varga M; Doros A; Smudla A; Fazakas J; Kóbori L
Orv Hetil; 2020 Aug; 161(32):1310-1321. PubMed ID: 32750019
[TBL] [Abstract][Full Text] [Related]
62. In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses.
Kang CK; Seong MW; Choi SJ; Kim TS; Choe PG; Song SH; Kim NJ; Park WB; Oh MD
Korean J Intern Med; 2020 Jul; 35(4):782-787. PubMed ID: 32460458
[TBL] [Abstract][Full Text] [Related]
63. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
Cao B; Wang Y; Wen D; Liu W; Wang J; Fan G; Ruan L; Song B; Cai Y; Wei M; Li X; Xia J; Chen N; Xiang J; Yu T; Bai T; Xie X; Zhang L; Li C; Yuan Y; Chen H; Li H; Huang H; Tu S; Gong F; Liu Y; Wei Y; Dong C; Zhou F; Gu X; Xu J; Liu Z; Zhang Y; Li H; Shang L; Wang K; Li K; Zhou X; Dong X; Qu Z; Lu S; Hu X; Ruan S; Luo S; Wu J; Peng L; Cheng F; Pan L; Zou J; Jia C; Wang J; Liu X; Wang S; Wu X; Ge Q; He J; Zhan H; Qiu F; Guo L; Huang C; Jaki T; Hayden FG; Horby PW; Zhang D; Wang C
N Engl J Med; 2020 May; 382(19):1787-1799. PubMed ID: 32187464
[TBL] [Abstract][Full Text] [Related]
64. Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19.
Zhu Z; Lu Z; Xu T; Chen C; Yang G; Zha T; Lu J; Xue Y
J Infect; 2020 Jul; 81(1):e21-e23. PubMed ID: 32283143
[TBL] [Abstract][Full Text] [Related]
65. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
[TBL] [Abstract][Full Text] [Related]
66. COVID-19 in Heart Transplant Recipients: A Multicenter Analysis of the Northern Italian Outbreak.
Bottio T; Bagozzi L; Fiocco A; Nadali M; Caraffa R; Bifulco O; Ponzoni M; Lombardi CM; Metra M; Russo CF; Frigerio M; Masciocco G; Potena L; Loforte A; Pacini D; Faggian G; Onorati F; Sponga S; Livi U; Iacovoni A; Terzi A; Senni M; Rinaldi M; Boffini M; Marro M; Jorgji V; Carrozzini M; Gerosa G
JACC Heart Fail; 2021 Jan; 9(1):52-61. PubMed ID: 33309578
[TBL] [Abstract][Full Text] [Related]
67. In severe COVID-19, adding lopinavir-ritonavir to usual care did not improve mortality at 28 days.
Singh A
Ann Intern Med; 2021 Jan; 174(1):JC3. PubMed ID: 33395331
[TBL] [Abstract][Full Text] [Related]
68. First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study.
Tschopp J; L'Huillier AG; Mombelli M; Mueller NJ; Khanna N; Garzoni C; Meloni D; Papadimitriou-Olivgeris M; Neofytos D; Hirsch HH; Schuurmans MM; Müller T; Berney T; Steiger J; Pascual M; Manuel O; van Delden C;
Am J Transplant; 2020 Oct; 20(10):2876-2882. PubMed ID: 32412159
[TBL] [Abstract][Full Text] [Related]
69. Safety and effectiveness concerns of lopinavir/ritonavir in COVID-19 affected patients: a retrospective series.
Lepage MA; Rozza N; Kremer R; Grunbaum A
Clin Toxicol (Phila); 2021 Jul; 59(7):644-647. PubMed ID: 33641562
[TBL] [Abstract][Full Text] [Related]
70. Respiratory and Gastrointestinal COVID-19 Phenotypes in Kidney Transplant Recipients.
Crespo M; Mazuecos A; Rodrigo E; Gavela E; Villanego F; Sánchez-Alvarez E; González-Monte E; Jiménez-Martín C; Melilli E; Diekman F; Zárraga S; Hernández D; Pascual J;
Transplantation; 2020 Nov; 104(11):2225-2233. PubMed ID: 32804802
[TBL] [Abstract][Full Text] [Related]
71. Lopinavir/ritonavir as a third agent in the antiviral regimen for SARS-CoV-2 infection.
Panagopoulos P; Petrakis V; Panopoulou M; Trypsianis G; Penlioglou T; Pnevmatikos I; Papazoglou D
J Chemother; 2021 May; 33(3):193-197. PubMed ID: 32530369
[TBL] [Abstract][Full Text] [Related]
72. Management of immunosuppression in lung transplant recipients and COVID-19 outcomes: an observational retrospective cohort-study.
Bes-Berlandier H; Coiffard B; Bermudez J; Demazes-Dufeu N; Coltey B; Boschi C; Colson P; Hraiech S; Reynaud-Gaubert M; Cassir N
BMC Infect Dis; 2024 May; 24(1):536. PubMed ID: 38807049
[TBL] [Abstract][Full Text] [Related]
73. Clinical characteristics and management of a liver transplanted patient admitted with SARS-CoV-2 infection.
De Gottardi A; Fratila C; Bertoli R; Cerny A; Magenta L; Gianella P; Majno-Hurst P; Ceschi A; Vanini G; Bernasconi E
Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):e141-e144. PubMed ID: 32565199
[TBL] [Abstract][Full Text] [Related]
74. Caution With the Use of Lopinavir/Ritonavir in Severely Ill Patients for the Treatment of SARS-CoV-2: A Report of Severe Jaundice.
Levy C; Lassailly G; Parmentier E; Duburcq T; Mathurin P; Poissy J
Am J Gastroenterol; 2020 Oct; 115(10):1716-1718. PubMed ID: 32858566
[TBL] [Abstract][Full Text] [Related]
75. Children in Critical Care Due to Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Experience in a Spanish Hospital.
García-Salido A; Leoz-Gordillo I; Martínez de Azagra-Garde A; Nieto-Moro M; Iglesias-Bouzas MI; García-Teresa MÁ; Cabrero-Hernández M; De Lama Caro-Patón G; Gochi Valdovinos A; González-Brabin A; Serrano-González A
Pediatr Crit Care Med; 2020 Aug; 21(8):e576-e580. PubMed ID: 32459790
[TBL] [Abstract][Full Text] [Related]
76. The impact of the SARS-CoV-2 pandemic and COVID-19 on lung transplantation in the UK: Lessons learned from the first wave.
Hardman G; Sutcliffe R; Hogg R; Mumford L; Grocott L; Mead-Regan SJ; Nuttall J; Dunn S; Seeley P; Clark S; Quigley R; Al-Attar N; Booth K; Dark JH; Fisher AJ;
Clin Transplant; 2021 Mar; 35(3):e14210. PubMed ID: 33368697
[TBL] [Abstract][Full Text] [Related]
77. Lopinavir/ritonavir use in Covid-19 infection: is it completely non-beneficial?
Owa AB; Owa OT
J Microbiol Immunol Infect; 2020 Oct; 53(5):674-675. PubMed ID: 32474026
[TBL] [Abstract][Full Text] [Related]
78. Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.
Arabi YM; Gordon AC; Derde LPG; Nichol AD; Murthy S; Beidh FA; Annane D; Swaidan LA; Beane A; Beasley R; Berry LR; Bhimani Z; Bonten MJM; Bradbury CA; Brunkhorst FM; Buxton M; Buzgau A; Cheng A; De Jong M; Detry MA; Duffy EJ; Estcourt LJ; Fitzgerald M; Fowler R; Girard TD; Goligher EC; Goossens H; Haniffa R; Higgins AM; Hills TE; Horvat CM; Huang DT; King AJ; Lamontagne F; Lawler PR; Lewis R; Linstrum K; Litton E; Lorenzi E; Malakouti S; McAuley DF; McGlothlin A; Mcguinness S; McVerry BJ; Montgomery SK; Morpeth SC; Mouncey PR; Orr K; Parke R; Parker JC; Patanwala AE; Rowan KM; Santos MS; Saunders CT; Seymour CW; Shankar-Hari M; Tong SYC; Turgeon AF; Turner AM; Van de Veerdonk FL; Zarychanski R; Green C; Berry S; Marshall JC; McArthur C; Angus DC; Webb SA;
Intensive Care Med; 2021 Aug; 47(8):867-886. PubMed ID: 34251506
[TBL] [Abstract][Full Text] [Related]
79. Prior SARS-CoV-2 infection may not alter the clinical course of COVID-19 in lung transplant recipients: A single-center experience.
Sindu D; Razia D; Grief K; Cherrier L; Omar A; Walia R; McAnally K; Buddhdev B; Tokman S
Clin Transplant; 2023 Nov; 37(11):e15071. PubMed ID: 37405931
[TBL] [Abstract][Full Text] [Related]
80. Clinical Features and Outcomes of 98 Patients Hospitalized with SARS-CoV-2 Infection in Daegu, South Korea: A Brief Descriptive Study.
Hong KS; Lee KH; Chung JH; Shin KC; Choi EY; Jin HJ; Jang JG; Lee W; Ahn JH
Yonsei Med J; 2020 May; 61(5):431-437. PubMed ID: 32390367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
